Lifera is a new global biopharmaceutical company with a mission to catalyse the growth of Saudi Arabia’s biopharmaceutical sector.
To achieve this vision, Lifera will deploy long-term capital for targeted local investments and international partnerships. These will strengthen Saudi Arabia’s domestic manufacturing, diagnostics and supply chains, accelerate skills and resource development, promote research and development, and enable cutting-edge technology transfer from global private sector partners.
Lifera is committed to promoting global health and wellbeing. Our long-term commitment to growing and strengthening the Saudi biopharmaceutical sector, investing in innovation and global partnerships, will help ensure access to life-saving and essential medicines and pharmaceutical products for people in Saudi Arabia, the region and around the world.
Lifera is a 100% owned PIF company.
Biologics and Innovation Platform
Source and localise global innovative assets through international partnerships to help Saudi Arabia localise innovative treatments and increase self-sufficiency and national health security.
Build and scale up key manufacturing capabilities along the value chain in Saudi Arabia to create a fully functional industry cluster and further enhance industry resilience.
Establish a regional pharmaceutical company that serves as a mature and at-scale commercial platform, to maximise patient access to essential medicines and amplifies the positive social impact of innovative treatments.
29 Nov 2023
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
27 Jun 2023